BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17663419)

  • 1. Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later.
    Public Affairs Committee of the Teratology Society
    Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):627-30. PubMed ID: 17663419
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.
    Teratology; 1994 Jun; 49(6):446-7. PubMed ID: 7747265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTIS special issue preface.
    Chambers C; Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):569. PubMed ID: 22847972
    [No Abstract]   [Full Text] [Related]  

  • 4. [History of Japanese Committee for Anatomical Nomenclature].
    Kimura K
    Kaibogaku Zasshi; 2008 Dec; 83(4):133-7. PubMed ID: 19108489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 6. The FDA at work: cutting-edge science promoting public health.
    Hilts PJ
    FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824
    [No Abstract]   [Full Text] [Related]  

  • 7. Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established.
    Kalter H
    Neurotoxicol Teratol; 2003; 25(2):131-282. PubMed ID: 12748001
    [No Abstract]   [Full Text] [Related]  

  • 8. The history of the editorship of Teratology during the period from July 1, 1976 to January 1, 1993.
    Brent RL
    Teratology; 2001 Feb; 63(2):100-5. PubMed ID: 11241433
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory aspects of teratology: role of the Food and Drug Administration.
    Kelsey FO
    Teratology; 1982 Apr; 25(2):193-9. PubMed ID: 7048616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
    Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratology Society Public Affairs Committee position paper: developmental toxicity of endocrine disruptors to humans.
    Barlow S; Kavlock RJ; Moore JA; Schantz SL; Sheehan DM; Shuey DL; Lary JM
    Teratology; 1999 Dec; 60(6):365-75. PubMed ID: 10590398
    [No Abstract]   [Full Text] [Related]  

  • 12. Pregnancy categories for prescription drugs.
    FDA Drug Bull; 1982 Dec; 12(3):24-5. PubMed ID: 7166220
    [No Abstract]   [Full Text] [Related]  

  • 13. Human teratogens: update 2010.
    Holmes LB
    Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.
    Kweder SL
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917
    [No Abstract]   [Full Text] [Related]  

  • 15. The neurobehavioral teratology of retinoids: a 50-year history.
    Adams J
    Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):895-905. PubMed ID: 20865785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT; Barash PG
    Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratology in the 20th century environmental causes of congenital malformations in humans and how they were established.
    Brent RL
    Neurotoxicol Teratol; 2004; 26(1):1-12. PubMed ID: 15001209
    [No Abstract]   [Full Text] [Related]  

  • 18. A journey shared; a task fulfilled.
    Raine CS
    J Neuroimmunol; 2010 Apr; 221(1-2):1-3. PubMed ID: 20382329
    [No Abstract]   [Full Text] [Related]  

  • 19. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 20. The fetal alcohol syndrome in mice: an animal model. Teratology 15:223-30. 1977.
    Chernoff GF
    Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):811-7. PubMed ID: 20973051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.